Table 3.
Mean 25(OH)D concentrations at baseline, post-intervention and change from baseline to post and mean 25(OH)D concentrations at baseline and post-intervention in vitamin D-sufficient and -insufficient participants
| Olive | Coconut | Supplement | Placebo | RM GLM ANCOVA (P) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n 15 | n 15 | n 17 | n 16 | |||||||||
| Mean | se | Mean | se | Mean | se | Mean | se | Time | Treatment | Time × treatment | ||
| Total | Baseline 25(OH)D (nmol/l) | 63·6 | 23·4 | 61·5 | 19·7 | 56·5 | 21·5 | 60·2 | 18·1 | 0·18 | 0·47 | < 0·001 |
| Post 25(OH)D (nmol/l) | 69·0 | 13·8 | 71·7 | 12·6 | 72·2 | 14·3 | 56·3 | 18·6 | ||||
| Change 25(OH)D (nmol/l) | 5·4 | 3·7 | 10·3 | 2·9 | 15·7 | 3·8 | –3·9 | 1·4 | < 0·001 | |||
| Sufficient | Baseline 25(OH)D (nmol/l) | 77·3 | 4·2 | 68·7 | 3·8 | 69·2 | 4·0 | 70·4 | 4·0 | 0·46 | 0·48 | 0·004 |
| Post 25(OH)D (nmol/l) | 74·2 | 3·8 | 74·9 | 3·4 | 75·8 | 3·6 | 66·8 | 3·6 | ||||
| Insufficient | Baseline 25(OH)D (nmol/l) | 36·1 | 4·4 | 32·2 | 5·9 | 32·6 | 4·4 | 38·9 | 4·6 | < 0·001 | 0·30 | < 0·001 |
| Post 25(OH)D (nmol/l) | 57·3 | 5·4 | 63·2 | 6·8 | 60·8 | 5·1 | 37·4 | 5·3 | ||||
25(OH)D, 25-hydroxyvitamin D; RM GLM ANCOVA, repeated-measures general linear model ANCOVA.
Data are presented as mean ± standard error.
RM GLM ANCOVA, controlling for BMI at baseline, explored differences in mean 25(OH)D between groups in sufficient and insufficient participants.
GLM ANCOVA, controlling for BMI at baseline, explored differences in mean 25(OH)D between groups in sufficient and insufficient participants.
P < 0·05 was considered statistically significant.